CGM market leader in U.S. pharmacies*

The FreeStyle Libre Portfolio can be easier to manage in pharmacy benefit.

Utilization management

Operational efficiencies

Cost savings

Pharmacy benefit for the FreeStyle Libre Portfolio

  • Priced 70% below the list price of other CGM systemsǂ

  • Lower payer costs§

  • Lower patient out of pocket costs§

  • #1 CGM in US pharmacies*

Doctor discussing FreeStyle Libre CGM system & prescription coverage with female patient
Pharmacy or Durable Medical Equipment (DME) video

Please contact us for more information.

* Data based on the number of sensors fulfilled in US Retail Pharmacy for FreeStyle Libre family of personal CGMs compared to the number of sensors for other personal CGM brands.
Ɨ Cost savings results from removal of manual prior authorization (PA) process. Under pharmacy benefit, PA’s can either be eliminated or automated via smart PA.
ǂ Based on a comparison of list prices of the FreeStyle Libre 2 system versus competitors’ CGM systems, assuming annual use of one receiver (or equivalent hardware) and quantity of transmitters and/or sensors according to use life.
§ First DataBank, April 2020; with assumption that patient cost-sharing is Tier 2 copay (average $30 per prescription). 
|| For FreeStyle Libre 14 day system: Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings, when you suspect readings may be inaccurate, or when you experience symptoms that may be due to high or low blood glucose. 
For FreeStyle Libre 2 system: Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.

ADC-17132 v4.0 01/21